KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Total Liabilities (2018 - 2025)

Historic Total Liabilities for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $3.3 billion.

  • BioNTech SE's Total Liabilities fell 724.69% to $3.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 billion, marking a year-over-year decrease of 724.69%. This contributed to the annual value of $3.3 billion for FY2024, which is 1220.52% up from last year.
  • BioNTech SE's Total Liabilities amounted to $3.3 billion in Q3 2025, which was down 724.69% from $3.5 billion recorded in Q2 2025.
  • BioNTech SE's 5-year Total Liabilities high stood at $6.5 billion for Q3 2021, and its period low was $7.0 million during Q4 2021.
  • In the last 5 years, BioNTech SE's Total Liabilities had a median value of $3.3 billion in 2024 and averaged $3.3 billion.
  • Per our database at Business Quant, BioNTech SE's Total Liabilities plummeted by 9938.18% in 2021 and then soared by 4702900.14% in 2022.
  • Quarter analysis of 5 years shows BioNTech SE's Total Liabilities stood at $7.0 million in 2021, then skyrocketed by 47029.0% to $3.3 billion in 2022, then fell by 9.69% to $3.0 billion in 2023, then rose by 12.21% to $3.3 billion in 2024, then increased by 0.46% to $3.3 billion in 2025.
  • Its last three reported values are $3.3 billion in Q3 2025, $3.5 billion for Q2 2025, and $2.4 billion during Q1 2025.